CytoStorm, INC
Helping Doctors Save Thousands Of Lives Of Overdosed Patients With Fentanyl, Vicodin, Oxycodone, Tylenol And Methamphetamine.
how do we do it? WE detoxifY THE blooD OF OVERDOSED PEOPLE
The number of drug overdoses has increased six-fold, since the year 2000. Over 100,000 people die from drug overdoses every year in the U.S. While the use of Narcan and Opvee have made it possible for more people to make it to a hospital people continue dyeing at a faster rate than before. To save lives, the Inflex System – a patented extracorporeal blood detoxification process - was invented. The Inflex System removes by adsorption drugs and toxins quickly and efficiently from a patient’s bloodstream. The drugs that can be removed from patients include Fentanyl, Oxycodone (OxyContin), Vicodin, acetaminophen (Tylenol), and Methamphetamine. Indeed, independent laboratory tests have verified that the Inflex System removes ±95% of the lethal doses of opioids in only 90 minutes as well of methamphetamine in only 3 hours.
ADDITIONAL TREATABLE CONDITIONS WITH THE CYTOSTORM SOLUTION
The CytoStorm Inflex System can potentially treat diverse conditions including H1N1, influenza, liver coma, sepsis, sickle cell anemia, and be used also as a bridge to liver transplant as independent laboratory studies have demonstrated that the Inflex System removes cytokines and toxins effectively and efficiently.
A SERIAL AND ENTREPRENEURIAL LEADERSHIP TEAM
Rudy Shepard Chairman of the Board and CEO
Lon Stone R&D Executive Vice President
Lon Stone R&D Executive Vice President
Mr. Shepard co-founded CytoStorm where he serves as the CEO. His prior experience includes leadership roles as CEO at Hancock Jaffe, Inc. (sold to LaMaitre Vascular), Founder and Chief Operating Officer at Innatech Laboratories, Inc. (sold to Dow Corning Wright), and CFO and Vice President at Hancock Laboratories, Inc. (sold to Johnson & Johnson).
Mr. Shepard invented the implantable “fixed” animal tissue graft to replace a human ACL. He possesses in depth experience as a Security Lawyer and as a CPA.
Lon Stone R&D Executive Vice President
Lon Stone R&D Executive Vice President
Lon Stone R&D Executive Vice President
Mr. Stone co-founded CytoStorm. He is also the Founder, Executive and Board Member of two NASDAQ medical device companies: Peregrine Pharmaceuticals, Inc. (Now Avid Bioservices, NASDAQ: CDMO), and American Diagnostics Corporation purchased by Hoffmann La Roche (ROG:Swiss).
Mr. Stone invented the first test to determine pregnancy before a missed menstrual cycle.
Anil Bhalani President and COO
Lon Stone R&D Executive Vice President
Anil Bhalani President and COO
Mr. Bhalani serves on CytoStorm’s Executive Committee. In this capacity, he ensures compliance with FDA requirements and assists with the design and development of manufacturing systems and workflows.
Mr. Bhalani is an experience operator as he was the Director of QA/RA at Masimo Corpoaration, Vice President of RA/QA and clinical programs at Medstone International, Inc., and Applied Medical Resouces. Mr. Bhalani has successfully supervised clinical trials, gathered information, and written PMA Applications and 510(k)s that were approved by the FDA.